Michael J. Miille
Directeur/Bestuurslid bij Sutter Davis Hospital Foundation
Profiel
Michael J.
Miille founded Sagres Discovery, Inc., where he worked as President & Chief Operating Officer from 2009 to 2010.
Dr. Miille also currently works at Sutter Davis Hospital Foundation, as Director from 2014.
Dr. Miille also formerly worked at Zoogen, Inc., as President & Chief Executive Officer, Lipomics Technologies, Inc., as Director, AgraQuest, Inc., as President & Chief Operating Officer, and Quanterra, Inc., as General Manager-Commercial Business.
Dr. Miille received his undergraduate degree from Stanford University and doctorate degree from the University of California, Davis.
Actieve functies van Michael J. Miille
Bedrijven | Functie | Begin |
---|---|---|
Sutter Davis Hospital Foundation | Directeur/Bestuurslid | 11-11-2014 |
Eerdere bekende functies van Michael J. Miille
Bedrijven | Functie | Einde |
---|---|---|
Lipomics Technologies, Inc.
Lipomics Technologies, Inc. BiotechnologyHealth Technology Lipomics is uniquely positioned as a leader in personalized medicine for metabolic disorders. Developing diagnostics for metabolic diseases. Its research and development efforts apply proprietary techniques in lipid profiling and data interpretation to identify clinically relevant biomarkers and validate their potential for diagnostic tests. Working with strategic partners, Lipomics Technologies is advancing its goal to develop clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation. Its service unit provides biomarker discovery and biological consultation services for advancing drug development with their pharmaceutical partners. The company generates high-quality quantitative profiles of lipid metabolites that are central to metabolic diseases. These metabolites include eicosanoids, acylcarnitines, sterols, bile acids and structural and energetic lipids. In addition to quantitative metabolite profiling, Lipomics provides bioinformatic analysis and biological interpretation services. | Directeur/Bestuurslid | 11-09-2009 |
Quanterra, Inc.
Quanterra, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dow Silicones Corp., Quanterra, Inc. provides lab analysis. Quanterra was acquired by Dow Silicones Corp. from IT Group, Inc. on June 26, 1998 for $5.75 million. | Corporate Officer/Principal | 01-01-1995 |
Sagres Discovery, Inc.
Sagres Discovery, Inc. Pharmaceuticals: MajorHealth Technology Sagres Discovery, Inc. researches and discovers oncology treatments. Its technology platform combines the biology of cancer formation in mouse models with the robustness of genomic technologies to enable discovery and clinical validation of human cancer genes. The company is headquartered in Davis, CA. | Oprichter | - |
Zoogen, Inc.
Zoogen, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Applied Biosystems, Inc., Zoogen, Inc. provides genetic analysis services to owners of domestic and exotic animals. The company is based in Davis, CA. Zoogen was acquired by Applera Corp. on April 05, 1996. | President | - |
AgraQuest, Inc.
AgraQuest, Inc. Chemicals: AgriculturalProcess Industries AgraQuest, Inc. develops pesticides and provides best management services. The company was founded in 1995 and is headquartered in Research Triangle Park, NC. | Algemeen Directeur | - |
Opleiding van Michael J. Miille
Stanford University | Undergraduate Degree |
University of California, Davis | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
AgraQuest, Inc.
AgraQuest, Inc. Chemicals: AgriculturalProcess Industries AgraQuest, Inc. develops pesticides and provides best management services. The company was founded in 1995 and is headquartered in Research Triangle Park, NC. | Process Industries |
Lipomics Technologies, Inc.
Lipomics Technologies, Inc. BiotechnologyHealth Technology Lipomics is uniquely positioned as a leader in personalized medicine for metabolic disorders. Developing diagnostics for metabolic diseases. Its research and development efforts apply proprietary techniques in lipid profiling and data interpretation to identify clinically relevant biomarkers and validate their potential for diagnostic tests. Working with strategic partners, Lipomics Technologies is advancing its goal to develop clinical diagnostic tools with an emphasis on high-density lipoprotein metabolism, diabetes, weight loss and inflammation. Its service unit provides biomarker discovery and biological consultation services for advancing drug development with their pharmaceutical partners. The company generates high-quality quantitative profiles of lipid metabolites that are central to metabolic diseases. These metabolites include eicosanoids, acylcarnitines, sterols, bile acids and structural and energetic lipids. In addition to quantitative metabolite profiling, Lipomics provides bioinformatic analysis and biological interpretation services. | Health Technology |
Quanterra, Inc.
Quanterra, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Dow Silicones Corp., Quanterra, Inc. provides lab analysis. Quanterra was acquired by Dow Silicones Corp. from IT Group, Inc. on June 26, 1998 for $5.75 million. | Commercial Services |
Zoogen, Inc.
Zoogen, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Applied Biosystems, Inc., Zoogen, Inc. provides genetic analysis services to owners of domestic and exotic animals. The company is based in Davis, CA. Zoogen was acquired by Applera Corp. on April 05, 1996. | Commercial Services |
Sagres Discovery, Inc.
Sagres Discovery, Inc. Pharmaceuticals: MajorHealth Technology Sagres Discovery, Inc. researches and discovers oncology treatments. Its technology platform combines the biology of cancer formation in mouse models with the robustness of genomic technologies to enable discovery and clinical validation of human cancer genes. The company is headquartered in Davis, CA. | Health Technology |
Sutter Davis Hospital Foundation | Commercial Services |